Compound Summary
piceatannol
Compound Information
piceatannol
Compound Name: | piceatannol |
Compound CID: | 667639 |
Synonyms: | piceatannol 10083-24-6 3-Hydroxyresveratol (E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol 3,5,3,4-Tetrahydroxystilbene" More... |
Iupac Name: | 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol |
InChI: | InChI=1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H/b2-1+ |
InChIKey: | CDRPUGZCRXZLFL-OWOJBTEDSA-N |
Canonical Smiles: | C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O |
Isomeric Smiles: | C1=CC(=C(C=C1/C=C/C2=CC(=CC(=C2)O)O)O)O |
Molecular Weight: | 244.24 |
Molecular Formula: | C14H12O4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
piceatannol
Molecular Weight: | 244.24 |
Molecular Formula: | C14H12O4 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 18 |
Complexity: | 282 |
Synonyms
piceatannol
| piceatannol | piceatannol |
|---|---|
piceatannol |
10083-24-6 |
3-Hydroxyresveratol |
(E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol |
3,5,3,4-Tetrahydroxystilbene" |
3,3,45-Tetrahydroxystilbene |
4-(E)-2-(3,5-dihydroxyphenyl)ethenylbenzene-1,2-diol |
3,3,4,5-Tetrahydroxystilbene |
Astringenin |
UNII-6KS3LS0D4F |
4339-71-3 |
4-(E)-2-(3,5-dihydroxyphenyl)vinylbenzene-1,2-diol |
C14H12O4 |
NSC-365798 |
6KS3LS0D4F |
CHEMBL69863 |
trans-Piceatannol |
CHEBI:28814 |
1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)- |
MFCD00221715 |
NSC365798 |
NSC622471 |
piceatanol |
3,3,4,5-Tetrahydroxy-trans-stilbene |
4-(1E)-2-(3,5-Dihydroxyphenyl)ethenyl-1,2-benzenediol |
4-(3,5-dihydroxystyryl)benzene-1,2-diol |
SMR001230734 |
SR-01000076056 |
MLS003171221 |
NSC 365798 |
NSC 622471 |
Astringinine |
1,2-Benzenediol, 4-2-(3,5-dihydroxyphenyl)ethenyl-, (E)- |
3,3,4,5-Stilbenetetrol |
CCRIS 9289 |
(E)-Piceatannol |
Piceatannol, powder |
1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)- |
BiomolKI_000023 |
BiomolKI2_000031 |
Lopac0_000915 |
SCHEMBL43541 |
BSPBio_001120 |
MLS002153321 |
MLS006010974 |
trans-3,3′,4,5′-Tetrahydroxystilbene |
BIDD:ER0001 |
SCHEMBL505561 |
BMK1-C11 |
cid_667639 |
MEGxp0_000245 |
DTXSID6040587 |
REGID_for_CID_667639 |
Stilbene-3,3,4,5-tetrol |
CHEBI:92460 |
ZINC14036 |
HMS1362H21 |
HMS1792H21 |
HMS1990H21 |
HMS2236B03 |
HMS3262H12 |
HMS3403H21 |
HMS3412J21 |
HMS3676J21 |
ML027 |
1,2-Benzenediol, 4-(1E)-2-(3,5-dihydroxyphenyl)ethenyl- |
Tox21_500915 |
3,3,4,5-tetrahydroxystilbene |
BDBM50045936 |
LMPK13090006 |
s3026 |
3,4,3,5-tetrahydroxystillbene |
AKOS015914951 |
AC-5281 |
CCG-100627 |
CS-5657 |
DB08399 |
FC-5001 |
FD18005 |
LP00915 |
NSC-622471 |
SDCCGSBI-0050890.P002 |
IDI1_002155 |
SMP2_000263 |
trans-3,3,4,5-Tetrahydroxystilbene" |
3,4,3,5-tetrahydroxy-trans-stilbene |
NCGC00094226-01 |
NCGC00094226-02 |
NCGC00094226-03 |
NCGC00094226-04 |
NCGC00094226-05 |
NCGC00094226-06 |
NCGC00094226-07 |
NCGC00094226-20 |
NCGC00261600-01 |
AS-18099 |
HY-13518 |
trans-3,3,4,5-tetrahydroxystilbene" |
3,4,3,5-tetrahydroxy-trans-stilbene |
AB0137762 |
EU-0100915 |
N2031 |
P1928 |
ST50825907 |
SW219501-1 |
W2087 |
C05901 |
K00089 |
P 0453 |
339P713 |
A800279 |
1, 4-2-(3,5-dihydroxyphenyl)ethenyl-, (E)- |
CU-00000000400-1 |
J-000228 |
Q7190608 |
SR-01000076056-1 |
SR-01000076056-6 |
SR-01000076056-9 |
BRD-K91509126-001-04-6 |
BRD-K91509126-001-05-3 |
(E)-4-2-(3,5Dihydroxyphenyl)ethenyl1,2-benzenediol |
F13BE9BB-B7D7-4D40-B31A-C15B953E033D |
(E)-4-2-(3,5-Dihydroxyphenyl)ethenyl1,2-benzenediol |
4-(1E)-2-(3,5-dihydroxyphenyl)ethenylbenzene-1,2-diol |
4-(1E)-2-(3,5-dihydroxyphenyl)vinylbenzene-1,2-diol |
5-(E)-2-(3,4-Dihydroxyphenyl)vinylbenzene-1,3-diol |
4-2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl-1,2-benzenediol |
4-(E)-2-(3,5-dihydroxyphenyl)vinylbenzene-1,2-diol(Piceatannol) |
4-2-(3,5-dihydroxyphenyl)-(E)-1-ethenyl-1,2-benzenediol(Piceatannol) |
(E)-4-2-(3,5Dihydroxyphenyl)ethenyl1,2-benzenediol, 3,3,4,5-Tetrahydroxy-trans-stilbene |
(E)-4-2-(3,5Dihydroxyphenyl)ethenyl1,2-benzenediol, 3,3a?4,5a?Tetrahydroxy-trans-stilbene |
Experimental Data
piceatannol
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 50.000000000000000 | umol/L | Unclear | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 100.000000000000000 | umol/L | Unclear | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -12.000000000000000 | NS | N2 | 24134630 | Inactive | ||||||
| Caenorhabditis elegans | 100.000000000000000 | umol/L | 18.000000000000000 | 21.300000000000000 | 0.180000000000000 | S | N2 | 28128482 | Active | ||||
| Caenorhabditis elegans | 50.000000000000000 | umol/L | 18.000000000000000 | 21.300000000000000 | 0.180000000000000 | S | N2 | 28128482 | Active |
Experimental Data Visualization
piceatannol
Statistics Data
piceatannol
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0.180000000000000 | 3 | 5 |
Statistics Data Visualization
piceatannol
